Verified Nov 2026
Batteries & E-Mobility
·

Chiyoda City, Tokyo
·
Since
Kyowa Kirin Co., Ltd. is a Japanese specialty pharmaceutical and biotechnology company headquartered in Tokyo, founded in 1949. With 1,000–5,000 employees and an estimated revenue between $1–5 billion, it operates as a subsidiary of Kirin Holdings. The company serves the automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors, developing treatments for oncology, nephrology, immunology, and central nervous system disorders, along with biochemicals including amino acids and nucleic acids.
Kyowa Kirin Co., Ltd. at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Headquarters
Chiyoda City, Tokyo
Certifications
ISO 14001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Overview
Kyowa Kirin Co., Ltd. is a Japanese specialty pharmaceutical and biotechnology company headquartered in Tokyo, founded in 1949. With 1,000–5,000 employees and an estimated revenue between $1–5 billion, it operates as a subsidiary of Kirin Holdings. The company serves the automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors, developing treatments for oncology, nephrology, immunology, and central nervous system disorders, along with biochemicals including amino acids and nucleic acids.
At a glance
Attribute | Detail |
|---|---|
Headquarters | Chiyoda City, Tokyo |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 14001 |
What Kyowa Kirin Co., Ltd. makes
Kyowa Kirin manufactures drugs such as Crysvita for hypophosphatemia and Poteligeo for acute myeloid leukemia, and develops next-generation antibodies and cell therapies.
Products and capabilities described on the company's own site include Emissions (source: kyowakirin.com).
Certifications
Kyowa Kirin Co., Ltd. is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — kyowakirin.com
Latest developments
2026-08-31 — Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans | Kyowa Kirin North America (kyowakirin.com)
2026-06-30 — FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience - Kyowa Kirin (kyowakirin.com)
2026-05-07 — Kyowa Kirin Plans the Creation of State-of-the-Art Research Hub to Further Strengthen Drug Discovery Capabilities - Kyowa Kirin (kyowakirin.com)
2026-01-30 — Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis - Kyowa Kirin (kyowakirin.com)
2026-01-21 — Kyowa Kirin is Planting Deep Roots in Sanford | Sanford Area Growth Alliance (growsanfordnc.com)
2025-10-31 — Boehringer Ingelheim acquires license from Kyowa Kirin aimed at developing a novel treatment for patients with autoimmune diseases (pharmafocuseurope.com)
Facilities
Kyowa Kirin Co., Ltd. is headquartered in Chiyoda City, Tokyo. Public sources also reference these locations:
Sanford, North Carolina — kyowakirin.com
Japan — kyowakirin.com
Company details
The company operates manufacturing and research facilities in Sanford, North Carolina, and Japan, and holds ISO 14001 certification. Kyowa Kirin Co., Ltd. has an estimated 1,000-5,000 employees, and is headquartered in Chiyoda City, Tokyo.
Frequently asked questions
What does Kyowa Kirin Co., Ltd. make?
Kyowa Kirin Co., Ltd. is a Japanese specialty pharmaceutical and biotechnology company headquartered in Tokyo, founded in 1949. With 1,000–5,000 employees and an estimated revenue between $1–5 billion, it operates as a subsidiary of Kirin Holdings. The company serves the automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors, developing treatments for oncology, nephrology, immunology, and central nervous system disorders, along with biochemicals including amino acids and nucleic acids.
Where is Kyowa Kirin Co., Ltd. headquartered?
Kyowa Kirin Co., Ltd. is headquartered in Chiyoda City, Tokyo.
How big is Kyowa Kirin Co., Ltd.?
Kyowa Kirin Co., Ltd. has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Kyowa Kirin Co., Ltd. hold?
Kyowa Kirin Co., Ltd. lists ISO 14001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
